MVAL vs. CDC
Compare and contrast key facts about VanEck Morningstar Wide Moat Value ETF (MVAL) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC).
MVAL and CDC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. MVAL is a passively managed fund by VanEck that tracks the performance of the Morningstar US Broad Value Wide Moat Focus Index - Benchmark TR Gross. It was launched on Mar 26, 2024. CDC is a passively managed fund by Crestview that tracks the performance of the Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. It was launched on Jul 2, 2014. Both MVAL and CDC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
MVAL vs. CDC - Performance Comparison
Loading graphics...
MVAL vs. CDC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MVAL VanEck Morningstar Wide Moat Value ETF | -1.89% | 14.17% | 6.10% |
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 9.03% | 8.96% | 7.99% |
Returns By Period
In the year-to-date period, MVAL achieves a -1.89% return, which is significantly lower than CDC's 9.03% return.
MVAL
- 1D
- 1.69%
- 1M
- -9.73%
- YTD
- -1.89%
- 6M
- 5.21%
- 1Y
- 14.55%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CDC
- 1D
- 0.77%
- 1M
- -2.88%
- YTD
- 9.03%
- 6M
- 8.89%
- 1Y
- 12.52%
- 3Y*
- 9.63%
- 5Y*
- 6.27%
- 10Y*
- 10.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
MVAL vs. CDC - Expense Ratio Comparison
MVAL has a 0.49% expense ratio, which is higher than CDC's 0.37% expense ratio.
Return for Risk
MVAL vs. CDC — Risk / Return Rank
MVAL
CDC
MVAL vs. CDC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Morningstar Wide Moat Value ETF (MVAL) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MVAL | CDC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.78 | 0.93 | -0.15 |
Sortino ratioReturn per unit of downside risk | 1.23 | 1.33 | -0.09 |
Omega ratioGain probability vs. loss probability | 1.16 | 1.19 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.14 | 1.23 | -0.09 |
Martin ratioReturn relative to average drawdown | 4.09 | 4.90 | -0.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MVAL | CDC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.78 | 0.93 | -0.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.50 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.76 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | 0.74 | -0.16 |
Correlation
The correlation between MVAL and CDC is 0.76, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
MVAL vs. CDC - Dividend Comparison
MVAL's dividend yield for the trailing twelve months is around 1.78%, less than CDC's 3.19% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MVAL VanEck Morningstar Wide Moat Value ETF | 1.78% | 1.75% | 0.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 3.19% | 3.36% | 3.32% | 4.24% | 3.48% | 2.65% | 2.48% | 3.04% | 3.37% | 2.81% | 2.99% | 3.17% |
Drawdowns
MVAL vs. CDC - Drawdown Comparison
The maximum MVAL drawdown since its inception was -19.56%, smaller than the maximum CDC drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for MVAL and CDC.
Loading graphics...
Drawdown Indicators
| MVAL | CDC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -19.56% | -21.37% | +1.81% |
Max Drawdown (1Y)Largest decline over 1 year | -13.29% | -11.27% | -2.02% |
Max Drawdown (5Y)Largest decline over 5 years | — | -21.37% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -21.37% | — |
Current DrawdownCurrent decline from peak | -10.20% | -3.07% | -7.13% |
Average DrawdownAverage peak-to-trough decline | -3.31% | -5.14% | +1.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.71% | 2.84% | +0.87% |
Volatility
MVAL vs. CDC - Volatility Comparison
VanEck Morningstar Wide Moat Value ETF (MVAL) has a higher volatility of 4.52% compared to VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) at 2.97%. This indicates that MVAL's price experiences larger fluctuations and is considered to be riskier than CDC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MVAL | CDC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.52% | 2.97% | +1.55% |
Volatility (6M)Calculated over the trailing 6-month period | 9.72% | 7.03% | +2.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.82% | 13.63% | +5.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.58% | 12.56% | +3.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.58% | 13.22% | +2.36% |